(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMULAÇÕES LIPOSSOMAIS DE INIBIDORES DE BCL

Em AnáliseInvention PatentPCT · US2022037371

Application data

Invention Patent FORMULAÇÕES LIPOSSOMAIS DE INIBIDORES DE BCL de CELATOR PHARMACEUTICALS, INC. — IPC A61K 31/00
Invention Patent FORMULAÇÕES LIPOSSOMAIS DE INIBIDORES DE BCL de CELATOR PHARMACEUTICALS, INC. — IPC A61K 31/00. Drawing published by the INPI in the Industrial Property Gazette.

Number

112024000780

Type

Invention Patent

Filing

07/15/2022

Publication

04/09/2024

PCT

US2022037371

Progress at the INPI

  1. Filing07/15/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 07/15/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 04/09/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

CELATOR PHARMACEUTICALS, INC.

US

Inventors

J. G. (pessoa física)

CA

L. W. (pessoa física)

CA

P. T. (pessoa física)

CA

P. L. (pessoa física)

CA

S. G. (pessoa física)

CA

Technical data

Priority claims

US

63/222,887 · 07/16/2021

Abstract

FORMULAÇÕES LIPOSSOMAIS DE INIBIDORES DE BCL. São fornecidos neste documento lipossomas compreendendo inibidores da proteína de linfoma de célula B (Bel), composições compreendendo tais lipossomas e métodos usando tais formulações para tratar distúrbios hiperproliferativos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

04/09/2024

RPI 2779

Alteração de dados cadastrais

#1.1

01/23/2024

RPI 2768

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.